Statins May Work in Alzheimer's Disease

JUNE 01, 2003

In a study of 44 patients with Alzheimer?s disease, researchers at the University of Texas Southwestern Medical Center found that statins lowered the patients? brain cholesterol levels. (Brain cholesterol contributes to the formation of amyloid plaques that damage brain cells.) During the 6-week study, participants were randomly assigned to receive either 40 mg daily of 1 of 3 different statins or 1 g daily of extended-release niacin?another kind of cholesterol-lowering drug. The results were published in the Archives of Neurology (April 21, 2003).

The researchers discovered that the 3 statin drugs reduced brain cholesterol levels by at least 20%, whereas the extended-release niacin reduced them by 10%. "This class of drugs [statins] may be potentially beneficial in the treatment of Alzheimer?s disease," said Gloria Vega, PhD, lead author of the study.



SHARE THIS SHARE THIS
0
 

Conference Coverage

Check back here regularly for live conference coverage from the American Academy of Pain Medicine and the upcoming American Pharmacists Association Meeting and Expo. 


 

Pharmacy Times Strategic Alliance
 

Pharmacist Education
Clinical features with downloadable PDFs


Next-Generation Pharmacist® Awards


3rd Annual Convenient Healthcare and Pharmacy Collaborative Conference


SIGN UP FOR THE PHARMACY TIMES NEWSLETTER
Personalize the information you receive by selecting targeted content and special offers.